Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Annals of Oncology

Topics

Medicine

Cancer Oncology

Internal Medicine

Hematology

Pulmonary And Respiratory Medicine

Show all topics

DOI

10.1093/annonc/mdz396

License

CC-BY

Other Formats

PDF